Gland Pharma Limited informed that upon the recommendation of the Nomination and Remuneration Committee, the Board of Directors meeting held on April 29, 2024 has inter-alia considered and approved the appointment of Mr. Satnam Singh Loomba as Chief Operating Officer (COO) and Senior Management Personnel of the Company with effect from May 1, 2024. Mr. Satnam Singh Loomba is a senior pharmaceutical and management professional with an extensive background in multi-cultural, global environments for pharmaceutical Operations & Business and proficient in several multi- functional departments. He has over 30 years of experience in API Operations & Development, Global Supply Planning & Operations in Manufacturing, Formulations, Global Material Sourcing, Corporate Strategic Business Planning, and Global Supply Chain for Global Markets.

He has experience in managing operations in Formulations in Pharmaceuticals, Narcotics, Cosmetics, Food and Alternate medicine like Sterile Injectables, Infusions, Aerosol based Inhalers, Sprays, Lyophilized products, Insulin, Lozenges, etc. He has been instrumental in attaining accreditations from USFDA, MHRA, EDQM Cofepris, TGA, MCC, Health Canada, ANVISA, PMDA, KFDA. Before joining Gland, Satnam was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.

Mr. Loomba has done his Master of Business Administration from University Business School, Chandigarh. He is also a graduate in Chemical Engineering from Andhra University, Visakhapatnam.